177 related articles for article (PubMed ID: 18221384)
21. Proteasome inhibitor, bortezomib, potently inhibits the growth of adult T-cell leukemia cells both in vivo and in vitro.
Satou Y; Nosaka K; Koya Y; Yasunaga JI; Toyokuni S; Matsuoka M
Leukemia; 2004 Aug; 18(8):1357-63. PubMed ID: 15190257
[TBL] [Abstract][Full Text] [Related]
22. Tumor growth inhibition induced in a murine model of human Burkitt's lymphoma by a proteasome inhibitor.
Orlowski RZ; Eswara JR; Lafond-Walker A; Grever MR; Orlowski M; Dang CV
Cancer Res; 1998 Oct; 58(19):4342-8. PubMed ID: 9766662
[TBL] [Abstract][Full Text] [Related]
23. Enhanced apoptosis mediates inhibition of EBV-transformed lymphoblastoid cell line proliferation by curcumin.
Ranjan D; Johnston TD; Reddy KS; Wu G; Bondada S; Chen C
J Surg Res; 1999 Nov; 87(1):1-5. PubMed ID: 10527697
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and mechanism of action of the proteasome inhibitor PS-341 in T-cell lymphomas and HTLV-I associated adult T-cell leukemia/lymphoma.
Nasr R; El-Sabban ME; Karam JA; Dbaibo G; Kfoury Y; Arnulf B; Lepelletier Y; Bex F; de Thé H; Hermine O; Bazarbachi A
Oncogene; 2005 Jan; 24(3):419-30. PubMed ID: 15543232
[TBL] [Abstract][Full Text] [Related]
25. Simvastatin induces apoptosis of Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines and delays development of EBV lymphomas.
Katano H; Pesnicak L; Cohen JI
Proc Natl Acad Sci U S A; 2004 Apr; 101(14):4960-5. PubMed ID: 15041742
[TBL] [Abstract][Full Text] [Related]
26. The proteasome inhibitor bortezomib promotes mitochondrial injury and apoptosis induced by the small molecule Bcl-2 inhibitor HA14-1 in multiple myeloma cells.
Pei XY; Dai Y; Grant S
Leukemia; 2003 Oct; 17(10):2036-45. PubMed ID: 14513055
[TBL] [Abstract][Full Text] [Related]
27. Growth inhibition of U937 leukemia cells by aqueous extract of Cordyceps militaris through induction of apoptosis.
Park C; Hong SH; Lee JY; Kim GY; Choi BT; Lee YT; Park DI; Park YM; Jeong YK; Choi YH
Oncol Rep; 2005 Jun; 13(6):1211-6. PubMed ID: 15870944
[TBL] [Abstract][Full Text] [Related]
28. The small organic compound HA14-1 prevents Bcl-2 interaction with Bax to sensitize malignant glioma cells to induction of cell death.
Manero F; Gautier F; Gallenne T; Cauquil N; Grée D; Cartron PF; Geneste O; Grée R; Vallette FM; Juin P
Cancer Res; 2006 Mar; 66(5):2757-64. PubMed ID: 16510597
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus-infected marmoset cells transfected with c-myc do not form lymphomas in mice with severe combined immunodeficiency.
Salimi B; O'Gorman MR; Variakojis D; Bendet M; Newman M; Poupko E; Katz BZ
Mol Genet Metab; 1998 Jul; 64(3):205-12. PubMed ID: 9719630
[TBL] [Abstract][Full Text] [Related]
30. Role of bcl-2 in Epstein-Barr virus-induced malignant conversion of Burkitt's lymphoma cell line Akata.
Komano J; Takada K
J Virol; 2001 Feb; 75(3):1561-4. PubMed ID: 11152530
[TBL] [Abstract][Full Text] [Related]
31. Histone deacetylase inhibitor depsipeptide (FK228) induces apoptosis in leukemic cells by facilitating mitochondrial translocation of Bax, which is enhanced by the proteasome inhibitor bortezomib.
Sutheesophon K; Kobayashi Y; Takatoku MA; Ozawa K; Kano Y; Ishii H; Furukawa Y
Acta Haematol; 2006; 115(1-2):78-90. PubMed ID: 16424655
[TBL] [Abstract][Full Text] [Related]
32. HIV-1 induces down-regulation of bcl-2 expression and death by apoptosis of EBV-immortalized B cells: a model for a persistent "self-limiting" HIV-1 infection.
De Rossi A; Ometto L; Roncella S; D'Andrea E; Menin C; Calderazzo F; Rowe M; Ferrarini M; Chieco-Bianchi L
Virology; 1994 Jan; 198(1):234-44. PubMed ID: 8259659
[TBL] [Abstract][Full Text] [Related]
33. Targeting mitochondria to overcome conventional and bortezomib/proteasome inhibitor PS-341 resistance in multiple myeloma (MM) cells.
Chauhan D; Li G; Podar K; Hideshima T; Mitsiades C; Schlossman R; Munshi N; Richardson P; Cotter FE; Anderson KC
Blood; 2004 Oct; 104(8):2458-66. PubMed ID: 15217830
[TBL] [Abstract][Full Text] [Related]
34. Involvement of hTERT in apoptosis induced by interference with Bcl-2 expression and function.
Del Bufalo D; Rizzo A; Trisciuoglio D; Cardinali G; Torrisi MR; Zangemeister-Wittke U; Zupi G; Biroccio A
Cell Death Differ; 2005 Nov; 12(11):1429-38. PubMed ID: 15920535
[TBL] [Abstract][Full Text] [Related]
35. In vitro effects of inhibin on apoptosis and apoptosis related proteins in human ovarian granulosa cells.
Denkova R; Bourneva V; Staneva-Dobrovski L; Zvetkova E; Baleva K; Yaneva E; Nikolov B; Ivanov I; Simeonov K; Timeva T; Yankov M
Endocr Regul; 2004 Jun; 38(2):51-5. PubMed ID: 15497928
[TBL] [Abstract][Full Text] [Related]
36. Proteasome inhibition induces hepatic stellate cell apoptosis.
Anan A; Baskin-Bey ES; Bronk SF; Werneburg NW; Shah VH; Gores GJ
Hepatology; 2006 Feb; 43(2):335-44. PubMed ID: 16440346
[TBL] [Abstract][Full Text] [Related]
37. Caspase activation and apoptosis in response to proteasome inhibitors.
Henderson CJ; Aleo E; Fontanini A; Maestro R; Paroni G; Brancolini C
Cell Death Differ; 2005 Sep; 12(9):1240-54. PubMed ID: 16094404
[TBL] [Abstract][Full Text] [Related]
38. Differential regulation of noxa in normal melanocytes and melanoma cells by proteasome inhibition: therapeutic implications.
Fernández Y; Verhaegen M; Miller TP; Rush JL; Steiner P; Opipari AW; Lowe SW; Soengas MS
Cancer Res; 2005 Jul; 65(14):6294-304. PubMed ID: 16024631
[TBL] [Abstract][Full Text] [Related]
39. The LCR of EBV makes Burkitt's lymphoma endemic.
Niller HH; Salamon D; Banati F; Schwarzmann F; Wolf H; Minarovits J
Trends Microbiol; 2004 Nov; 12(11):495-9. PubMed ID: 15488390
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of constitutive NF-kappa B activation in mantle cell lymphoma B cells leads to induction of cell cycle arrest and apoptosis.
Pham LV; Tamayo AT; Yoshimura LC; Lo P; Ford RJ
J Immunol; 2003 Jul; 171(1):88-95. PubMed ID: 12816986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
